<DOC>
	<DOCNO>NCT02615262</DOCNO>
	<brief_summary>Perioperative administration steroid demonstrate reduce systemic inflammatory response infant undergoing cardiac surgery cardiopulmonary bypass . However , data effect steroid clinical outcome lack . Hence hypothesis present study : intraoperative administration dexamethasone reduce complication rate improve clinical outcome infant undergo repair congenital heart defect cardiopulmonary bypass .</brief_summary>
	<brief_title>Intraoperative Dexamethasone Pediatric Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>elective repair congenital heart defect cardiopulmonary bypass absence write informed consent sign parent guardian ; hypoplastic leave heart syndrome ; participation conflict randomised study ; emergency surgery ; inotropic support prior surgery ; mechanical ventilation prior surgery ; bacterial , viral fungal infection precede 30 day ; gestational age le 37 week ; perinatal central nervous system damage .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Pediatric cardiac surgery</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>Steroids</keyword>
	<keyword>Cardiopulmonary bypass</keyword>
	<keyword>Congenital heart defect</keyword>
	<keyword>Infants</keyword>
</DOC>